Katherine Cook to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Katherine Cook has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.029
-
Figg WD, Cook K, Clarke R. Aromatase inhibitor plus ovarian suppression as adjuvant therapy in premenopausal women with breast cancer. . 2014; 15(12):1586-7.
Score: 0.029